Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 71

1.

Excess Blood Flow Response to Acute Resistance Exercise in Individuals Who are Obese or Nonobese.

Lipford GF, Evans RK, Acevedo EO, Wolfe LG, Franco RL.

J Strength Cond Res. 2017 Nov;31(11):3120-3127. doi: 10.1519/JSC.0000000000001748.

PMID:
27941490
2.

CD14+ cells are required for IL-12 response in bovine blood mononuclear cells activated with Toll-like receptor (TLR) 7 and TLR8 ligands.

Buza J, Benjamin P, Zhu J, Wilson HL, Lipford G, Krieg AM, Babiuk LA, Mutwiri GK.

Vet Immunol Immunopathol. 2008 Dec 15;126(3-4):273-82. doi: 10.1016/j.vetimm.2008.08.001. Epub 2008 Aug 20.

PMID:
18789542
3.

Identification of RNA sequence motifs stimulating sequence-specific TLR8-dependent immune responses.

Forsbach A, Nemorin JG, Montino C, Müller C, Samulowitz U, Vicari AP, Jurk M, Mutwiri GK, Krieg AM, Lipford GB, Vollmer J.

J Immunol. 2008 Mar 15;180(6):3729-38.

4.

Immunology. The toll of cathepsin K deficiency.

Krieg AM, Lipford GB.

Science. 2008 Feb 1;319(5863):576-7. doi: 10.1126/science.1154207. No abstract available.

PMID:
18239112
5.

Characterization of conserved viral leader RNA sequences that stimulate innate immunity through TLRs.

Forsbach A, Nemorin JG, Völp K, Samulowitz U, Montino C, Müller C, Tluk S, Hamm S, Bauer S, Lipford GB, Vollmer J.

Oligonucleotides. 2007 Winter;17(4):405-17.

PMID:
18072859
6.

Characterization of suppressive oligodeoxynucleotides that inhibit Toll-like receptor-9-mediated activation of innate immunity.

Peter M, Bode K, Lipford GB, Eberle F, Heeg K, Dalpke AH.

Immunology. 2008 Jan;123(1):118-28. Epub 2007 Oct 23.

7.

Therapeutic vaccination with papillomavirus E6 and E7 long peptides results in the control of both established virus-induced lesions and latently infected sites in a pre-clinical cottontail rabbit papillomavirus model.

Vambutas A, DeVoti J, Nouri M, Drijfhout JW, Lipford GB, Bonagura VR, van der Burg SH, Melief CJ.

Vaccine. 2005 Nov 1;23(45):5271-80. Epub 2005 Jul 11.

PMID:
16054734
8.

Differential expression regulation of the alpha and beta subunits of the PA28 proteasome activator in mature dendritic cells.

Ossendorp F, Fu N, Camps M, Granucci F, Gobin SJ, van den Elsen PJ, Schuurhuis D, Adema GJ, Lipford GB, Chiba T, Sijts A, Kloetzel PM, Ricciardi-Castagnoli P, Melief CJ.

J Immunol. 2005 Jun 15;174(12):7815-22.

9.

CpG oligodeoxynucleotides stimulate IFN-gamma-inducible protein-10 production in human B cells.

Vollmer J, Jurk M, Samulowitz U, Lipford G, Forsbach A, Wüllner M, Tluk S, Hartmann H, Kritzler A, Müller C, Schetter C, Krieg AM.

J Endotoxin Res. 2004;10(6):431-8.

PMID:
15588427
10.

TLRs govern neutrophil activity in aspergillosis.

Bellocchio S, Moretti S, Perruccio K, Fallarino F, Bozza S, Montagnoli C, Mosci P, Lipford GB, Pitzurra L, Romani L.

J Immunol. 2004 Dec 15;173(12):7406-15.

11.

Chemically synthesized protein as tumour-specific vaccine: immunogenicity and efficacy of synthetic HPV16 E7 in the TC-1 mouse tumour model.

Welters MJ, Filippov DV, van den Eeden SJ, Franken KL, Nouta J, Valentijn AR, van der Marel GA, Overkleeft HS, Lipford G, Offringa R, Melief CJ, van Boom JH, van der Burg SH, Drijfhout JW.

Vaccine. 2004 Dec 2;23(3):305-11.

PMID:
15530672
12.

Comparison of CpG s-ODNs, chromatin immune complexes, and dsDNA fragment immune complexes in the TLR9-dependent activation of rheumatoid factor B cells.

Marshak-Rothstein A, Busconi L, Lau CM, Tabor AS, Leadbetter EA, Akira S, Krieg AM, Lipford GB, Viglianti GA, Rifkin IR.

J Endotoxin Res. 2004;10(4):247-51.

PMID:
15373969
13.

Toll-like receptor 9 binds single-stranded CpG-DNA in a sequence- and pH-dependent manner.

Rutz M, Metzger J, Gellert T, Luppa P, Lipford GB, Wagner H, Bauer S.

Eur J Immunol. 2004 Sep;34(9):2541-50.

14.

Immunoglobulin-like transcripts ILT2, ILT3 and ILT7 are expressed by human dendritic cells and down-regulated following activation.

Ju XS, Hacker C, Scherer B, Redecke V, Berger T, Schuler G, Wagner H, Lipford GB, Zenke M.

Gene. 2004 Apr 28;331:159-64.

PMID:
15094202
15.

Species-specific recognition of single-stranded RNA via toll-like receptor 7 and 8.

Heil F, Hemmi H, Hochrein H, Ampenberger F, Kirschning C, Akira S, Lipford G, Wagner H, Bauer S.

Science. 2004 Mar 5;303(5663):1526-9. Epub 2004 Feb 19.

16.

The Toll-like receptor 7 (TLR7)-specific stimulus loxoribine uncovers a strong relationship within the TLR7, 8 and 9 subfamily.

Heil F, Ahmad-Nejad P, Hemmi H, Hochrein H, Ampenberger F, Gellert T, Dietrich H, Lipford G, Takeda K, Akira S, Wagner H, Bauer S.

Eur J Immunol. 2003 Nov;33(11):2987-97.

17.

Vaccination of mice against invasive aspergillosis with recombinant Aspergillus proteins and CpG oligodeoxynucleotides as adjuvants.

Bozza S, Gaziano R, Lipford GB, Montagnoli C, Bacci A, Di Francesco P, Kurup VP, Wagner H, Romani L.

Microbes Infect. 2002 Nov;4(13):1281-90.

PMID:
12443892
18.

CpG-DNA aided cross-presentation of soluble antigens by dendritic cells.

Maurer T, Heit A, Hochrein H, Ampenberger F, O'Keeffe M, Bauer S, Lipford GB, Vabulas RM, Wagner H.

Eur J Immunol. 2002 Aug;32(8):2356-64.

19.

Postexposure prophylaxis against prion disease with a stimulator of innate immunity.

Sethi S, Lipford G, Wagner H, Kretzschmar H.

Lancet. 2002 Jul 20;360(9328):229-30.

PMID:
12133662
20.

Established human papillomavirus type 16-expressing tumors are effectively eradicated following vaccination with long peptides.

Zwaveling S, Ferreira Mota SC, Nouta J, Johnson M, Lipford GB, Offringa R, van der Burg SH, Melief CJ.

J Immunol. 2002 Jul 1;169(1):350-8.

21.

Human TLR7 or TLR8 independently confer responsiveness to the antiviral compound R-848.

Jurk M, Heil F, Vollmer J, Schetter C, Krieg AM, Wagner H, Lipford G, Bauer S.

Nat Immunol. 2002 Jun;3(6):499. No abstract available.

PMID:
12032557
22.

Human TLR9 confers responsiveness to bacterial DNA via species-specific CpG motif recognition.

Bauer S, Kirschning CJ, Häcker H, Redecke V, Hausmann S, Akira S, Wagner H, Lipford GB.

Proc Natl Acad Sci U S A. 2001 Jul 31;98(16):9237-42. Epub 2001 Jul 24.

23.

Bacterial CpG-DNA triggers activation and maturation of human CD11c-, CD123+ dendritic cells.

Bauer M, Redecke V, Ellwart JW, Scherer B, Kremer JP, Wagner H, Lipford GB.

J Immunol. 2001 Apr 15;166(8):5000-7.

24.

Bacterial CpG-DNA activates dendritic cells in vivo: T helper cell-independent cytotoxic T cell responses to soluble proteins.

Sparwasser T, Vabulas RM, Villmow B, Lipford GB, Wagner H.

Eur J Immunol. 2000 Dec;30(12):3591-7.

26.

The role of immunostimulatory CpG-DNA in septic shock.

Wagner H, Lipford GB, Häcker H.

Springer Semin Immunopathol. 2000;22(1-2):167-71. Review. No abstract available.

PMID:
10944811
27.

Immunostimulatory DNA sequences help to eradicate intracellular pathogens.

Wagner H, Häcker H, Lipford GB.

Springer Semin Immunopathol. 2000;22(1-2):147-52. Review. No abstract available.

PMID:
10944809
28.

CpG-DNA-mediated transient lymphadenopathy is associated with a state of Th1 predisposition to antigen-driven responses.

Lipford GB, Sparwasser T, Zimmermann S, Heeg K, Wagner H.

J Immunol. 2000 Aug 1;165(3):1228-35.

29.
30.

Immunostimulatory CpG-oligonucleotides induce functional high affinity IL-2 receptors on B-CLL cells: costimulation with IL-2 results in a highly immunogenic phenotype.

Decker T, Schneller F, Kronschnabl M, Dechow T, Lipford GB, Wagner H, Peschel C.

Exp Hematol. 2000 May;28(5):558-68.

PMID:
10812246
31.

HPV type 16 protein E7 HLA-A2 binding peptides are immunogenic but not processed and presented.

Bauer M, Wagner H, Lipford GB.

Immunol Lett. 2000 Jan 10;71(1):55-9.

PMID:
10709786
32.

CpG-DNA activates in vivo T cell epitope presenting dendritic cells to trigger protective antiviral cytotoxic T cell responses.

Vabulas RM, Pircher H, Lipford GB, Häcker H, Wagner H.

J Immunol. 2000 Mar 1;164(5):2372-8.

34.

Hematopoietic remodeling triggered by CpG DNA.

Lipford GB, Sparwasser T.

Curr Top Microbiol Immunol. 2000;247:119-29. Review. No abstract available.

PMID:
10689783
35.

Consequences of bacterial CpG DNA-driven activation of antigen-presenting cells.

Sparwasser T, Lipford GB.

Curr Top Microbiol Immunol. 2000;247:59-75. Review. No abstract available.

PMID:
10689779
36.

Immunostimulatory CpG-oligonucleotides cause proliferation, cytokine production, and an immunogenic phenotype in chronic lymphocytic leukemia B cells.

Decker T, Schneller F, Sparwasser T, Tretter T, Lipford GB, Wagner H, Peschel C.

Blood. 2000 Feb 1;95(3):999-1006.

37.

Guanosine-rich oligodeoxynucleotides induce proliferation of macrophage progenitors in cultures of murine bone marrow cells.

Lang R, Hültner L, Lipford GB, Wagner H, Heeg K.

Eur J Immunol. 1999 Nov;29(11):3496-506.

38.

DNA activates human immune cells through a CpG sequence-dependent manner.

Bauer M, Heeg K, Wagner H, Lipford GB.

Immunology. 1999 Aug;97(4):699-705.

39.

CpG-oligodeoxynucleotides co-stimulate primary T cells in the absence of antigen-presenting cells.

Bendigs S, Salzer U, Lipford GB, Wagner H, Heeg K.

Eur J Immunol. 1999 Apr;29(4):1209-18.

40.

Bacterial DNA as immune cell activator.

Lipford GB, Heeg K, Wagner H.

Trends Microbiol. 1998 Dec;6(12):496-500. Review.

PMID:
10036729
41.

Immunostimulatory CpG-oligodeoxynucleotides cause extramedullary murine hemopoiesis.

Sparwasser T, Hültner L, Koch ES, Luz A, Lipford GB, Wagner H.

J Immunol. 1999 Feb 15;162(4):2368-74.

42.

CpG-DNA-specific activation of antigen-presenting cells requires stress kinase activity and is preceded by non-specific endocytosis and endosomal maturation.

Häcker H, Mischak H, Miethke T, Liptay S, Schmid R, Sparwasser T, Heeg K, Lipford GB, Wagner H.

EMBO J. 1998 Nov 2;17(21):6230-40.

43.

Bacterial DNA as an evolutionary conserved ligand signalling danger of infection to immune cells.

Heeg K, Sparwasser T, Lipford GB, Häcker H, Zimmermann S, Wagner H.

Eur J Clin Microbiol Infect Dis. 1998 Jul;17(7):464-9. Review.

PMID:
9764548
44.

Bacterial DNA and immunostimulatory CpG oligonucleotides trigger maturation and activation of murine dendritic cells.

Sparwasser T, Koch ES, Vabulas RM, Heeg K, Lipford GB, Ellwart JW, Wagner H.

Eur J Immunol. 1998 Jun;28(6):2045-54.

45.

CpG oligodeoxynucleotides trigger protective and curative Th1 responses in lethal murine leishmaniasis.

Zimmermann S, Egeter O, Hausmann S, Lipford GB, Röcken M, Wagner H, Heeg K.

J Immunol. 1998 Apr 15;160(8):3627-30.

46.

Immunostimulatory DNA: sequence-dependent production of potentially harmful or useful cytokines.

Lipford GB, Sparwasser T, Bauer M, Zimmermann S, Koch ES, Heeg K, Wagner H.

Eur J Immunol. 1997 Dec;27(12):3420-6.

PMID:
9464831
47.

CpG-containing synthetic oligonucleotides promote B and cytotoxic T cell responses to protein antigen: a new class of vaccine adjuvants.

Lipford GB, Bauer M, Blank C, Reiter R, Wagner H, Heeg K.

Eur J Immunol. 1997 Sep;27(9):2340-4.

PMID:
9341778
48.

Macrophages sense pathogens via DNA motifs: induction of tumor necrosis factor-alpha-mediated shock.

Sparwasser T, Miethke T, Lipford G, Erdmann A, Häcker H, Heeg K, Wagner H.

Eur J Immunol. 1997 Jul;27(7):1671-9.

PMID:
9247576
49.

Bacterial DNA causes septic shock.

Sparwasser T, Miethke T, Lipford G, Borschert K, Häcker H, Heeg K, Wagner H.

Nature. 1997 Mar 27;386(6623):336-7. No abstract available.

PMID:
9121548
50.

HLA-A2-restricted peripheral blood cytolytic T lymphocyte response to HPV type 16 proteins E6 and E7 from patients with neoplastic cervical lesions.

Evans C, Bauer S, Grubert T, Brucker C, Baur S, Heeg K, Wagner H, Lipford GB.

Cancer Immunol Immunother. 1996 Mar;42(3):151-60.

PMID:
8640843

Supplemental Content

Loading ...
Support Center